Litecoin Down 5% After SEC Delays ETF Filing Over Fraud Concerns
The SEC's delay in Canary Capital's Litecoin ETF application, coupled with a call for public comments, led to a 5% drop in Litecoin's price, despite no clear rejection signal.
The SEC delayed Canary Capital’s application for a Litecoin ETF today, opening public comments over the proposal’s compliance with regulatory requirements. The price of LTC fell 5% after the announcement.
The public comment aspect doesn’t appear to signal the Commission’s intentions; this could be a standard delaying tactic. Nonetheless, the market immediately took it as a bearish signal.
Will the SEC Reject Canary’s Litecoin ETF?
A few months ago, analysts proposed that the Litecoin ETF was more likely to win SEC approval than any other altcoin ETF. Its Polymarket odds briefly reached 85% in February, and today’s SEC deadline further spurred community hype.
However, the SEC instead decided to delay this application, including a request for public comments in its notice:
“The Commission seeks and encourages interested persons to provide comments on the proposed rule change. The Commission asks that commenters address the sufficiency of [whether] the proposal… is designed to prevent fraudulent and manipulative acts and practices or raises any new or novel concerns not previously contemplated by the Commission,” it read.
To be clear, it is not positive that this request constitutes a bearish development. The SEC is fielding a lot of altcoin ETF proposals right now, and it recently delayed several.
It even opened public comments for a Litecoin ETF proposal in February. In other words, this might be a standard delaying tactic. Unfortunately, the market hasn’t taken it well.
Litecoin (LTC) Daily Price Chart. Source:
TradingView
Litecoin’s price fell quickly after the Commission delayed this application, dropping 5% at its lowest point. Polymarket’s odds of a Litecoin ETF approval in Q2 2025 also plummeted, but the chances of a 2025 approval in general remained steady.
The most bullish expectations listed Q2 as a potential time for altcoin ETF approvals, and this bet is now looking rather unlikely.
Odds of a Litecoin ETF in Q2 2025. Source:
Polymarket
In other words, things could be a lot worse. James Seyffart, an ETF analyst who predicted the Litecoin delay, didn’t comment on the public comment aspect. It seems like a stretch to claim that the SEC is signaling its intent to refuse this or any other altcoin ETF proposal.
Still, the market can react harshly to such developments in the short term, and traders are repositioning their bets on the altcoin.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Cyclical stocks always peak when they're “cheapest” — Citrini, the “chip influencer” who was the earliest to be bullish on AI hardware, is now quietly exiting
Citrini, once the most prominent bull in AI hardware, has now significantly reduced his semiconductor holdings and currently holds some short positions. He believes that the financing structure for AI infrastructure has shifted from tech giants' own cash flows to equity and debt markets, and that sentiment alone could sever the funding chain and impact fundamentals. Strategically, he is long Meta and short Google. Citrini also asserts that the bottleneck in AI pharmaceutical development is not computational power, but rather a "lack of monkeys."
New Zealand Dollar gains ground to near 0.5700 as RBNZ rate hike bets rise
Median survival prolonged by 5.7 months! Roche (RHHBY.US) lung cancer new drug wins in head-to-head trial, major catalyst for oncology business
Roche's investigational lung cancer drug divarasib extended patient survival by nearly six months compared to competing therapies in a late-stage clinical trial, promising to further strengthen the Swiss pharmaceutical company's oncology portfolio.
Global Aging Reshapes Equity and Bond Investment Logic? Pension "Longevity Bill" Accelerates Accumulation, Equities, Bonds, and Private Equity Welcome Massive Long-term Capital
As people live longer and birth rates decline, pension funds are required to allocate their assets for retirement periods that can last decades. Meanwhile, the number of workers contributing to these systems is decreasing.
Crypto prices
More
